The following is a summary of “Effect of postoperative normothermic intraperitoneal chemotherapy on the prognosis of MPM patients receiving CRS+HIPEC: a single-center case-control study,” published in ...
Dr. Johnny Ong, MD, Associate Professor, Department of Sarcoma, Peritoneal and Rare Tumors, National Cancer Centre Singapore** commented: “One of the limitations of cytoreductive surgery (CRS) is the ...
For most patients younger than age 60 with polycythemia vera (PV) who are not considered high risk, cytoreductive therapies are withheld despite being highly effective. 2 Commerce Drive Suite 100 ...
Department of Clinical Hematology, Institute of Hematology and Blood Transfusion, Prague, Czechia Introduction: Inherited bone marrow failure (IBMF) syndromes are caused by mutations forming ...
The Shorespan-007 trial will investigate the new drug among patients with essential thrombocythemia who have not previously received cytoreductive therapy. A second phase 3 clinical trial has been ...